Table 3:

Primary and secondary outcome indicators at baseline, 12 months and 18 months

	Baseline		12 months			18 months
	Control	Intervention	Control	Intervention	P value	Control	Intervention	P value
Number of Households	1140	1172	1032	1075		1024	1028
Number of individuals	1611	1650	1331	1414		1268	1338
Primary outcomes
Mean SBP (mm Hg)	130.3 (20.8)	130.3 (20.5)	128.3 (14.95)	127.6 (15.04)	0.18	129.3 (15.31)	129 (15.36)	0.98
Individuals on drug therapy n(%)	342	367	210	275		137	181
Mean daily drug pills consumed	1.21 (0.80)	1.22 (0.81)	1.0 (1.34)	0.984 (1.20)	0.73	0.97 (1.38)	0.97 (1.17)	0.88
Secondary outcomes
Mean Body mass index (Kg/m2)	20.4 (4.03)	20.5 (3.61)	20.62 (2.18)	20.84 (2.25)	0.02	20.60 (2.13)	20.7 (2.19)	0.18
Mean Waist-hip ratio of included members	0.9 (0.002)	0.9 (0.002)	0.92 (0.002)	0.91 (0.002)	0.07	0.9167 (0.003)	0.92 (0.003)	0.68
INTERHEART risk score for household (Median (IQR))	10 (6)	10 (6)	8.3 (3.61)	8.20 (3.64)	0.50	8.28 (3.12)	8.25 (3.58)	0.88
Tobacco consumption
Individual who smoke n(%)	274 (17.0)	269 (16.3)	191 (14.4)	173 (12.2)	0.45	182 (14.4)	158 (11.8)	0.38
Individual who chew n(%)	782 (48.5)	800 (48.5)	555 (41.7)	454 (32.1)	<0.001	513 (40.5)	476 (35.6)	0.09

All values are adjusted for the effect of clustering and baseline parameters